Heparin for patients with growth restricted fetus: A prospective randomized controlled trial

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 23, Issue 9, 2010, Pages 980-987

  Yu, Yan Hong ^a   Shen, Li Yong ^a   Zou, Hua ^a   Wang, Zhi Jian ^a   Gong, Shi Peng ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; fetal growth restriction; hemorrheology; heparin; ultrasonography

Indexed keywords

ANTITHROMBIN III; DEXTRAN 40; HEPARIN; PROTHROMBIN; SALVIA MILTIORRHIZA EXTRACT; THROMBOPLASTIN;

ABSENCE OF SIDE EFFECTS; ADULT; APGAR SCORE; APOPTOSIS; ARTICLE; BIPARIETAL DISTANCE; BIRTH WEIGHT; BLOOD ANALYSIS; BLOOD RHEOLOGY; BLOOD VISCOSITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ERYTHROCYTE AGGREGATION; FEMALE; FETUS; FETUS ECHOGRAPHY; FETUS GROWTH; GESTATIONAL AGE; GROWTH RATE; HEAD CIRCUMFERENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; PARTIAL THROMBOPLASTIN TIME; PLACENTA; PLASMA VISCOSITY; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE COUNT; TREATMENT DURATION; TREATMENT OUTCOME; TROPHOBLAST;

ADULT; ANTICOAGULANTS; BIRTH WEIGHT; FEMALE; FETAL DEVELOPMENT; FETAL GROWTH RETARDATION; GLUCOSE; HEPARIN; HUMANS; MOLECULAR WEIGHT; PLANT PREPARATIONS; PREGNANCY; PREGNANCY OUTCOME; SALVIA MILTIORRHIZA; ULTRASONOGRAPHY, PRENATAL; YOUNG ADULT;

EID: 77955913189     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767050903443459     Document Type: Article

References (28)

1. Minior VK, Divon MY. Fetal growth restriction at term: myth or reality? Obstet Gynecol 1998;92:57-60.
2. Smith GC, Pell JP, Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet 2001;357:2002-2006.
3. de Boo HA, Harding JE. The developmental origins of adult disease (Barker) hypothesis. Aust N Z J Obstet Gynaecol 2006;46:4-14.
4. Barker DJ. In utero programming of cardiovascular disease. Theriogenology 2000;53:555-574.
5. Nuyt AM. Mechanisms underlying developmental programming of elevated blood pressure and vascular dysfunction: evidence from human studies and experimental animal models. Clin Sci (Lond) 2008;114:1-17.
6. Sullivan MC, Hawes K, Winchester SB, Miller RJ. Developmental origins theory from prematurity to adult disease. J Obstet Gynecol Neonatal Nurs 2008;37:158-164.
7. Ross MG, Beall MH. Adult sequelae of intrauterine growth restriction. Semin Perinatol 2008;32:213-218.
8. Bellart J, Gilabert R, Fontcuberta J, Carreras E, Miralles RM, Cabero L. Coagulation and fibrinolytic parameters in normal pregnancy and in pregnancy complicated by intrauterine growth retardation. Am J Perinatol 1998;15:81-85.
9. Nelson DM. Apoptotic changes occur in syncytiotrophoblast of human placental villi where fibrin type fibrinoid is deposited at discontinuities in the villous trophoblast. Placenta 1996;17: 387-391.
10. Smith SC, Baker PN, Symonds EM. Increased placental apoptosis in intrauterine growth restriction. Am J Obstet Gynecol 1997;177:1395-1401.
11. Smith SC, Baker PN, Symonds EM. Placental apoptosis in normal human pregnancy. Am J Obstet Gynecol 1997; 177:57-65.
12. Macara L, Kingdom JC, Kaufmann P, Kohnen G, Hair J, More IA, Lyall F, Greer IA. Structural analysis of placental terminal villi from growth-restricted pregnancies with abnormal umbilical artery Doppler waveforms. Placenta 1996; 17:37-48.
13. Wang Z. Mechanism on modulating platelet function of activating blood circulation and removing stasis herbs. Zhongguo Zhong Xi Yi Jie He Za Zhi 1992;12:567-570
14. Wu B, Liu M, Zhang S. Dan Shen agents for acute ischemic stroke. Stroke 2007;38:3095-3096. (Pubitemid 350035709)
15. Zhu XX. Effect of danshan and persantin on the alteration of platelet aggregation and microcirculation in diabetics. Zhonghua Nei Ke Za Zhi 1985;24:197-199, 253.
16. Riyazi N, Leeda M, de Vries JI, Huijgens PC, van Geijn HP, Dekker GA. Low-molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: a preliminary study. Eur J Obstet Gynecol Reprod Biol 1998;80: 49-54.
17. Liu Y, Gao P, Xie Y, Wang S, Dai M, Jiang S. Role of placental apoptosis in fetal growth restriction. Zhonghua Fu Chan Ke Za Zhi 2002;37:721-722.
18. Cohen M, Antman EM. Superiority of enoxaparin over unfractionated heparin for the treatment of acute coronary syndromes. Pharmacotherapy 2002;22:546-546
19. Antovic A, Blomback M, Bremme K, He S. The assay of overall haemostasis potential used to monitor the low molecular mass (weight) heparin, dalteparin, treatment in pregnant women with previous thromboembolism. Blood Coagul Fibrinolysis 2002;13:181-186.
20. Bar J, Mashiah R, Cohen-Sacher B, Hod M, Orvieto R, Ben-Rafael Z, Lahav J. Effect of thrombophylaxis on uterine and fetal circulation in pregnant women with a history of pregnancy complications. Thromb Res 2001;101: 235-241.
21. Sun LZ, Zhao WY, Hong L, Peng T. Apoptosis gene expression profiling of placental trophoblast cells in patients with pregnancy induced hypertension. Zhonghua Fu Chan Ke Za Zhi 2003;38:604-607.
22. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995;270:1189-1192.
23. Hammer A, Blaschitz A, Daxbock C, Walcher W, Dohr G. Fas and Fas-ligand are expressed in the uteroplacental unit of first-trimester pregnancy. Am J Reprod Immunol 1999; 41:41-51.
24. Ganapathy R, Whitley GS, Cartwright JE, Dash PR, Thilaganathan B. Effect of heparin and fractionated heparin on trophoblast invasion. Hum Reprod 2007;22:2523-2527.
25. Bukowski R, Smith GC, Malone FD, Ball RH, Nyberg DA, Comstock CH, Hankins GD, Berkowitz RL, Gross SJ, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, D'Alton ME. FASTER Research Consortium. Fetal growth in early pregnancy and risk of delivering low birth weight infant: prospective cohort study. BMJ 2007;334:836-840.
26. Smith GC, Smith MF, McNay MB, Fleming JE. Firsttrimester growth and the risk of low birth weight. N Engl J Med 1998;339:1817-1822.
27. Nicolaides KH, Peters MT, Vyas S, Rabinowitz R, Rosen DJ, Campbell S. Relation of rate of urine production to oxygen tension in small-for-gestational- age fetuses. Am J Obstet Gynecol 1990;162:387-391.
28. Dickey RP, Gasser RF. Ultrasound evidence for variability in the size and development of normal human embryos before the tenth post-insemination week after assisted reproductive technologies. Hum Reprod 1993;8:331-337.